Olive, Kenneth P <br/><br/>
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.  [electronic resource] 

 -  Science (New York, N.Y.)  Jun 2009 
 - 1457-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.1171362  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Apoptosis--drug effects<br/>Carcinoma, Pancreatic Ductal--blood supply<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Deoxycytidine--administration & dosage<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm<br/>Hedgehog Proteins--antagonists & inhibitors<br/>Humans<br/>Kruppel-Like Transcription Factors--metabolism<br/>Mice<br/>Neoplasm Transplantation<br/>Neovascularization, Pathologic<br/>Pancreatic Neoplasms--blood supply<br/>Receptors, G-Protein-Coupled--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Smoothened Receptor<br/>Stromal Cells--drug effects<br/>Veratrum Alkaloids--administration & dosage<br/>Zinc Finger Protein GLI1<br/>Gemcitabine